L

Lepu Biopharma Co Ltd
HKEX:2157

Watchlist Manager
Lepu Biopharma Co Ltd
HKEX:2157
Watchlist
Price: 5.52 HKD -6.12% Market Closed
Market Cap: 10B HKD

Wall Street
Price Targets

Price Targets Summary
Lepu Biopharma Co Ltd

Wall Street analysts forecast Lepu Biopharma Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Lepu Biopharma Co Ltd is 10.59 HKD with a low forecast of 10.48 HKD and a high forecast of 10.9 HKD.

Lowest
Price Target
10.48 HKD
90% Upside
Average
Price Target
10.59 HKD
92% Upside
Highest
Price Target
10.9 HKD
97% Upside
Lepu Biopharma Co Ltd Competitors:
Price Targets
002675
Yantai Dongcheng Biochemicals Co Ltd
20% Upside
EDIT
Editas Medicine Inc
103% Upside
TVTX
Travere Therapeutics Inc
21% Upside
LTRN
Lantern Pharma Inc.
444% Upside
VOR
Vor Biopharma Inc
399% Upside
NVAX
Novavax Inc
90% Upside
IMMX
Immix Biopharma Inc
47% Upside
TIL
Instil Bio Inc
794% Upside

Revenue
Forecast

Revenue Estimate
Lepu Biopharma Co Ltd

The compound annual growth rate of Lepu Biopharma Co Ltd's revenue for the next 3 years is 67%.

N/A
Past Growth
67%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Lepu Biopharma Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Lepu Biopharma Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Lepu Biopharma Co Ltd's stock price target?
Price Target
10.59 HKD

According to Wall Street analysts, the average 1-year price target for Lepu Biopharma Co Ltd is 10.59 HKD with a low forecast of 10.48 HKD and a high forecast of 10.9 HKD.

What is Lepu Biopharma Co Ltd's Revenue forecast?
Projected CAGR
67%

The compound annual growth rate of Lepu Biopharma Co Ltd's revenue for the next 3 years is 67%.

Back to Top